Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

(2016) Jan Beyer-Westendorf et al.   EUROPACE

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC

(2016) Anja Katholing et al.   THROMBOSIS AND HAEMOSTASIS

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation

(2016) J. Hecker et al.   THROMBOSIS AND HAEMOSTASIS

Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry

(2015) J. Beyer-Westendorf et al.   EUROPACE

Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation

(2015) Giacomo Zoppellaro et al.   Expert Opinion On Drug Safety

Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013

(2015) Carlos Martinez et al.   HEART

To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort

(2015) Serena Granziera et al.   Internal and Emergency Medicine

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

(2015) Laila Staerk et al.   BMJ-British Medical Journal

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

(2015) Laila Staerk et al.   BMJ-British Medical Journal

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

(2014) Emily C. O’Brien et al.   AMERICAN HEART JOURNAL

The European Stroke Organisation (ESO) Guidelines

(2014) T. Steiner et al.   International Journal of Stroke

Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation

(2013) Winnie W. Nelson et al.   AMERICAN JOURNAL OF CARDIOLOGY

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

(2013) Giuseppe Mancia et al.   BLOOD PRESSURE

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Persistence of Warfarin Therapy for Residents in Long-term Care Who Have Atrial Fibrillation

(2013) Aarti A. Patel et al.   CLINICAL THERAPEUTICS

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Significant Underuse of Warfarin in Patients with Nonvalvular Atrial Fibrillation: Results from the China National Stroke Registry

(2013) Chunjuan Wang et al.   Journal of Stroke & Cerebrovascular Diseases

Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

(2013) Manesh R. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

(2012) Tara Gomes et al.   ARCHIVES OF INTERNAL MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

(2012) T. Wilke et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Bleeding risk assessment and management in atrial fibrillation patients

(2011) Laurent Fauchier et al.   THROMBOSIS AND HAEMOSTASIS

Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.

(2011) Luciano Crippa et al.   THROMBOSIS AND HAEMOSTASIS

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

(2010) Margaret C. Fang et al.  

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

(2010) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stroke in the Very Elderly: Hospital Care, Case Fatality and Disposition

(2009) Gustavo Saposnik et al.   CEREBROVASCULAR DISEASES

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

(2008) A. M. GALLAGHER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS